Multiple immuno-regulatory defects in type-1 diabetes

Journal of Clinical Investigation

Volumn 109, Issue 1, 2002, Pages 131-140

  Kukreja, Anjli ^a   Cost, Giulia ^a   Marker, John ^a   Zhang, Chenhui ^a   Sun, Zhong ^a   Lin Su, Karen ^a   Ten, Svetlana ^a   Sanz, Maureen ^a   Exley, Mark ^b   Wilson, Brian ^c   Porcelli, Steven ^d   Maclaren, Noel ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIGENICITY; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NATURAL KILLER CELL; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

EID: 0036141438     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0213605     Document Type: Article

References (69)

1. Type 1 diabetes
2. Functional diversity of helper T lymphocytes
3. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice
4. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunosumulation?
5. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
6. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man - Macrophages, lymphocytes, and interferon-gamma containing cells
7. Interferon expression in the pancreases of patients with type 1 diabetes
8. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice
9. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci
10. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice
11. Cytokine expression in unstimulated PBMC of children with type 1 diabetes and subjects positive for diabetes-associated antibodies
12. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x
13. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups
14. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
15. Requirement for Valphal4 NKT cells in IL-12-mediated rejection of tumors
16. NKT cells and tumor immunity - A double-edged sword
17. Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpba-chains
18. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells
19. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-[alpha]/[beta] T cells demonstrates preferential use of several V[beta] genes and an invariant TCR [alpha] chain
20. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans
21. NKT cells are phenotypically and functionally diverse
22. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice
23. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4
24. Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice
25. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes
26. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus
27. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis
28. Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)
29. Differential expression of NK T cell V[alpha]24J[alpha]Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
30. CD4-CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
31. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation
32. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
33. Organ specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of possible cause of autoimmune disease
34. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro
35. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
36. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, JA-2 and IA-2beta predict immune-mediated (type 1) diabetes in relatives
37. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatoty T cells that control autoimmune diabetes
38. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes
39. Non-canonical Valpha24JalphaQ T cells with conservative alpha chain CDR3 region amino acid substitutions are restricted by CD1d
40. Multiple differences in gene expression in regulatoty Valpha24JalphaQT cells from identical twins discordant for type 1 diabetes
41. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1
42. Dendritic cell lineage, plasticity and cross-regulation
43. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes
44. Positive selection ofinvariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells
45. Polymorphism of human CD1 genes
46. Impaired yield, phenotype, and function monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes
47. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis
48. Tolerance mechanism in experimental ovarian and gastric autoimmune diseases
49. Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat
50. Multiple immunoregulatory defects underlie immune mediated (type 1) diabetes in man and mouse
51. Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood
52. T lymphopenia in genetically obese-diabetic Wistar fatty rats: Effects of body weight reduction on T cells
53. T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent
54. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus
55. Influence of blood glucose levels on peripheral lymphocytes in patients with diabetes mellitus
56. Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution
57. Similar alterations of lymphocyte subpopulations in type 1 and type 2 diabetes
58. The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis
59. Organ-specific autoimmunity
60. Th1 to Th2 cytokine shifts in non obese diabetic mice: Sometimes an outcome, rather than the cause of diabetes resistance elicited by immunostimulation
61. Dissociated production of interleukin-2 and immune gamma-interferon by phytohaemoagglutinin stimulated peripheral mononuclear cells in type 1 (insulin-dependent) diabetes
62. Acquired defect in IL-2 production in patients with type 1 diabetes mellitus
63. Interleukin 2 and soluble interleukin 2 receptor secretion defect in vitro in newly diagnosed type 1 diabetic patients
64. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice
65. Specific deficiency, of p56[lck] expression in T lymphocytes form type 1 diabetic patients
66. A defect in bone marrow derived dendritic cell maturation in the nonobese diabetic mouse
67. Splenic macrophages from the NOD mouse are defective in the ability to present antigen
68. Activation of NKT cells by α-galactosylceramide treatment prevents the onset and reoccurrence of autoimmune type 1 diabetes
69. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice